Skip to main content

Navneet Hakhu reflects on CTAD 2021

By Commentary, Community Events, In the News

Alzheimer’s disease (AD) clinical trials require the enrollment of two people: a participant and a study partner. Study partners play critical roles for trial success. Yet, little is known about the impact of study partners, especially in trials that enroll individuals with mild cognitive impairment (MCI). At this year’s Clinical Trials on Alzheimer’s Disease (CTAD) conference in Boston, Navneet Hakhu from the Grill/Gillen lab presented data about who study partners are in these important clinical trials. He showed that the prevalence of adult child and other dyads was much lower than that of spousal dyads. But importantly, these adult child and other dyads were much more likely…

Read More

Michelle Nuño, PhD reflects on CTAD 2021

By Commentary, Community Events, In the News

Cognitive assessments are a crucial part of Alzheimer’s disease studies as these help track cognitive decline; however, these assessments may be subject to a practice effect, an improvement in scores due to familiarity with the assessment. Practice effects can mask cognitive decline, so it is important to understand whether these exist in commonly used assessments. At this year’s Clinical Trials on Alzheimer’s Disease (CTAD) conference in Boston, Michelle Nuño in the labs of Drs. Joshua Grill and Daniel Gillen, presented the group’s work investigating whether the letter fluency test, a commonly used assessment, is subject to a practice effect. Through…

Read More

Elizabeth Head, PhD is Expertscape World Expert in Intellectual Disability

By Carousel Slider, Commentary, In the News

UCI MIND In The News: Dec 3 is International Day of Persons with Disabilities. So congratulations to Dr. Elizabeth Head of University of California, Irvine — Recognized as an Expertscape World Expert in Intellectual Disability: https://expertscape.com/ex/intellectual+disability Related posts: Alzheimer’s treatment study seeks volunteers, including two sites in Portland KATU News: “We all have to do more because this is about the most important medical problem we face as a society today,” said Dr. Josh Grill, a member of the AHEAD Study leadership team and director of the UC Irvine Institute for Memory Impairments and Neurological Disorders. Grill said… Aducanumab update…

Read More

Spotlight on Care hits 2,000 downloads!

By Commentary, In the News

UCI MIND’s podcast, Spotlight on Care, just hit 2,000 downloads! Subscribe today wherever you get your podcasts, and you’ll hear our hosts and special guests share stories, experiences, tips, and advice on caring for loved ones affected by Alzheimer’s and other dementias. Learn more at mind.uci.edu/podcast Related posts: COVID-19 Vaccine Community Information Panel Join UCI School of Pharmacy and Pharmaceutical Sciences on Thursday, February 11th for a community information session with their Scientists & Pharmacists to learn the basics about COVID-19 Vaccines and what to expect as they become more widely available. Registration links below! Can’t make it on February 11th?…

Read More

Today is #GivingTuesday!

By Commentary, Community Events, In the News

TODAY is #GivingTuesday – a day that celebrates generosity in all its forms!  In honor of this global generosity movement, make a gift today to UCI MIND. We hope you will expand our capacity to conduct promising research and advance progress toward ending Alzheimer’s disease by supporting the UCI MIND Alzheimer’s Disease Excellence Fund. GIVE NOW Related posts: COVID-19 Vaccine Community Information Panel Join UCI School of Pharmacy and Pharmaceutical Sciences on Thursday, February 11th for a community information session with their Scientists & Pharmacists to learn the basics about COVID-19 Vaccines and what to expect as they become more widely…

Read More

Support UCI MIND on #GivingTuesday!

By Commentary, Community Events, In the News

Tomorrow is #GivingTuesday – a day that celebrates generosity in all its forms! In honor of this global generosity movement, consider making a gift today to UCI MIND. We rely on the support of people like you in our community to advance life-changing research and accelerate the fight against Alzheimer’s disease, a devastating illness that impacts more than 6 million Americans and their families. GIVE NOW We hope you will support us by Giving Tuesday, November 30th, 2021 #GivingTuesday Related posts: UCI MIND’s First-Ever Virtual Gala Warms Hearts, Opens Minds, Drives Donations Both On and Offline UC Irvine’s Institute for…

Read More

#NationalCaregiversMonth

By Commentary, Community Events, In the News

This month is #NationalCaregiversMonth – a time to recognize and honor family caregivers across California and raise awareness to increase support for caregivers. Many caregivers work and provide care which can make it challenging to maintain their own well-being. . As a caregiver, it’s essential to take care of yourself, too. The California Department of Aging has compiled a list of resources to assist you in this role. https://bit.ly/ALZDcare Related posts: María M. Corrada, ScM, ScD at AAIC 2021 … MIND Matters | Quarterly Newsletter | Summer 2021 Message from the Director Dear Friends of UCI MIND, The summer of…

Read More

Often people do not realize that they are considered a caregiver

By Commentary

Often people do not realize that they are considered a caregiver, but if you are providing care or assistance to a family member or a friend, YOU are a caregiver. The California Department of Aging has compiled a list of resources to assist you in this role. Whether you are a new or seasoned caregiver, protecting the health and safety of you and your loved ones is always a top priority. https://bit.ly/ALZDcare

Read More

One in five people

By Commentary, In the News

One in five people will develop dementia. Keep your body and brain healthy. Learn more about the facts and figures of Alzheimer’s disease: https://bit.ly/ALZDaware Related posts: Tracking the Alzheimer’s-Down syndrome connection By the time they’re 40, most people with Down syndrome develop beta amyloid plaques in the brain — a key characteristic of Alzheimer’s disease. Scientists believe this is because they have an extra copy of chromosome 21, which carries an amyloid-producing gene. Many people with Down syndrome do develop Alzheimer’s… The FDA has approved Aduhelm. What now? Join UCI MIND Director Joshua Grill, PhD & Neurologist Gaby Thai, MD…

Read More

One in six baby boomers

By Commentary, In the News

One in six baby boomers who live to be 65 years of age and older will develop Alzheimer’s disease. Keep your body and brain healthy. For healthy lifestyle tips and resources, see https://bit.ly/BRAINhealth Related posts: Charles Glabe Named 2020 National Academy of Inventors Fellow Contributed by Hal S. Stern, PhD and Frank M. LaFerla, PhD It is our pleasure to congratulate Charles Glabe, Distinguished Professor of Molecular Biology and Biochemistry, on being named a 2020 fellow of the National Academy of Inventors. Among his achievements, Professor Glabe is being recognized for the creation of… UCI Institute MINDing Aducanamab UCI MIND…

Read More